CassianKYeeMD

Oncology • Houston, TX

Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Yee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yee's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1991 - 1994
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1989 - 1991
University of ManitobaClass of 1986

Certifications & Licensure

CA State Medical License 1990 - Present
TX State Medical License 2014 - 2024
WA State Medical License 1991 - 2015

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 2009
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Biological Therapy in Treating Patients With Metastatic Melanoma Start of enrollment: 1995 Oct 01
Completed
Phase 1, Phase 2
Biological Therapy in Treating Patients With Metastatic Melanoma Start of enrollment: 2002 Oct 01
Completed
Phase 1
Biological Therapy in Treating Patients With Metastatic Melanoma Start of enrollment: 2001 Nov 01
Completed
Phase 1
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer Start of enrollment: 2004 Oct 01
Completed
Phase 1
Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma Start of enrollment: 2003 May 01
Completed
Phase 1
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma Start of enrollment: 2006 Dec 01
Completed
Phase 1
Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma Start of enrollment: 2007 Sep 01
Completed
Phase 1, Phase 2
Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma Start of enrollment: 2009 Jun 01
No longer available
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma Start of enrollment: 2010 Apr 01
Terminated
Phase 1
CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma Start of enrollment: 2015 Jan 22
Completed
Phase 2
Adoptive Therapy Using Antigen-Specific CD4 T-Cells Start of enrollment: 2016 Dec 01
Withdrawn
Phase 1
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors Start of enrollment: 2019 Aug 09
Terminated
Phase 1
T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer Start of enrollment: 2018 Jul 16
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

122 citations
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Yared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, Wai Chin Foo, Salah-Eddine Bentebibel
Cancer Cell. 2022-05-09
946 citations
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor...
Cassian Yee, John A. Thompson, David R. Byrd, Stanley R. Riddell, Patrick C. Roche
Proceedings of the National Academy of Sciences of the United States of America. 2002-12-10
77 citations
Adoptive therapy with CD8+ T cells: it may get by with a little help from its friends
William Y. Ho, Cassian Yee, Philip D. Greenberg
The Journal of Clinical Investigation. 2002-11-15

Lectures

Update on T-Cell Receptor Therapy
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

AI Bowel Cancer Test Can Tell Whether Patients Need ChemotherapyJuly 31st, 2024
MD Anderson and Collaborators to Launch Project Studying T Cells on International Space StationJuly 31st, 2024
MD Anderson to Launch Project Studying T Cells in SpaceJuly 31st, 2024
Join now to see all

CassianKYeeMD

Dr. Yee is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.